LIPIGEM Gemfibrozil 300mg Capsule 1's
RXDRUG-DR-XY22829-1pc
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications/Uses
Treatment of hyperlipidemia. Lipigem has been used in long-term treatment and prophylaxis of patients with coronary heart disease.
Dosage/Direction for Use
Usual Dose: 0.6-1.2 g daily in divided doses.
Administration
Should be taken on an empty stomach: Take 30 min before meals.
Contraindications
Lipigem should not be given to patients with impaired liver and kidney function or with primary biliary cirrhosis. It should not be given during pregnancy.
Special Precautions
Impaired liver & kidney function, primary biliary cirrhosis.
Use In Pregnancy & Lactation
Lipigem is contraindicated during pregnancy.
Adverse Reactions
There have been occasional reports of nausea, vomiting, abdominal pain, anorexia, heartburn and diarrhea. Drowsiness, allergy and elevation of serum creatine kinase values have also been reported.
Drug Interactions
Anticoagulants, lovastatin.
Storage
Store at room temperature.
Action
Antihyperlipidemic agent.
Pharmacology: Gemfibrozil is a lipid-regulating agent which lowers elevated serum lipids primarily by decreasing serum triglycerides and total serum cholesterol. It reduces elevated plasma concentrations of triglycerides and to a somewhat smaller extent, elevated plasma concentrations of cholesterols, the effect is particularly evident in a reduction of elevated concentrations of very low density lipoproteins. It is also recommended by the American Diabetes Association for type II B dyslipidemias ie, high triglycerides, high LDL, low HDL as first-line therapy.
Pharmacology: Gemfibrozil is a lipid-regulating agent which lowers elevated serum lipids primarily by decreasing serum triglycerides and total serum cholesterol. It reduces elevated plasma concentrations of triglycerides and to a somewhat smaller extent, elevated plasma concentrations of cholesterols, the effect is particularly evident in a reduction of elevated concentrations of very low density lipoproteins. It is also recommended by the American Diabetes Association for type II B dyslipidemias ie, high triglycerides, high LDL, low HDL as first-line therapy.
MedsGo Class
Dyslipidaemic Agents
Features
Brand
Lipigem
Full Details
Dosage Strength
300 mg
Drug Ingredients
- Gemfibrozil
Drug Packaging
Capsule 1's
Generic Name
Gemfibrozil
Dosage Form
Capsule
Registration Number
DR-XY22829
Drug Classification
Prescription Drug (RX)
Please sign in so that we can notify you about a reply